Donor Funding for Health in Low - & Middle - Income Countries, 2002-2010. Wexler A, Valentine A, and Kates J. (2013)


Trends between 2002 and 2010 provide an indication of donor priorities and important shifts. For instance, the U.S. remained the largest donor to health in each year over the period and provided the greatest share of its ODA for health. Additionally, the donor mix has shifted over time, in part due to the entrance of new donors, particularly the Global Fund, which was created in 2002 and has been the second largest donor since 2006. The U.S. and the Global Fund combined accounted for more than half of total donor funding for health in 2010.

Download Publication

Asia-Pacific Aspirations: Perspectives for a Post-2015 Development Agenda - Asia Pacific Regional MDGs Report 2012/13. ESCAP, ADB and UNDP. (2013)


The Regional MDGs Report comes at a critical juncture when one big final push is needed to achieve the MDGs in less than 1,000 days. As efforts are scaled up, citizens and leaders of the world are also discussing the possible framework of a transformative development agenda beyond 2015. Thus, this 2012/13 report, while identifying the areas needing accelerated actions and emerging challenges, is intended to inform this global process.

Download Publication

The World Health Report 2013: Research for Universal Health Coverage. WHO. (2013)


The World health report: research for universal health coverage focuses on the importance of research in advancing progress towards universal health coverage. In addition, it identifies the benefits of increased investment in health research by low- and middle-income countries using case studies from around the world, and proposes ways to further strengthen this type of research.

Download Publication

Global Update on HIV Treatment 2013: Results, Impact and Opportunities. WHO, UNICEF, and UNAIDS. (2013)


This publication reports on the progress being made in the global scale-up in the use of antiretroviral (ARV) medicines in low- and middle-income countries, the challenges that are being overcome or that await solutions and the opportunities for building on the achievements of the past decade.

Download Publication

Treatment 2015. UNAIDS. (2013)


Treatment 2015 provides a results-driven framework to expedite and greatly expand coverage. With less than 1000 days before the end of 2015, much work remains to be done. The WHO’s new 2013 guidelines on The Use of Antiretroviral Drugs for Treating and Preventing HIV Infection recommend a CD4 threshold of 500 for initiation of HIV treatment. As an important step towards getting to zero AIDS-related deaths, countries should be encouraged to prioritize immediate efforts to ensure that all people eligible for HIV treatment have access to it.

Download Publication

Consolidated Guidelines on The Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. WHO. (2013)


These guidelines were updated in late 2012 and early 2013. The ARV regimens now available, even in the poorest countries, are safer, simpler, more efficacious and more affordable than ever before. New testing strategies and approaches are enabling earlier diagnosis of HIV in a wider range of settings, and new, more affordable technologies for monitoring people receiving ART are becoming available. Countries are moving towards triple-drug regimens and simplified programming for PMTCT that emphasizes the long-term health of pregnant women and mothers living with HIV as well as their children. Important new evidence has shown that ARV drugs offer significant benefits in preventing HIV transmission.

Download document

Pacific Consultation on Legal and Policy Barriers to Accessing HIV Services for PLHIV and Key Affected Populations. Mesurier R l. (2013).


UNAIDS in the Pacific coordinated a process in mid April 2013 toreview laws and policies in seven Pacific nations (Fiji, Kiribati, Papua New Guinea, Samoa, Solomon Islands, Tuvalu and Vanuatu) which impact on access to HIV services for PLHIV and key populations. This initiative was supported by the UNDP Pacific Centre, the Regional Rights Resource Team (RRRT) of the Secretariat of the Pacific Community (SPC), the Economic and Social Commission for Asia and the Pacific (ESCAP), UNAIDS Asia Pacific Regional Support Team and ILO Pacific.

Download Publication

Intellectual Property Rights and Access to Affordable ARVs in China. UNDP. (2013)


This paper documents the recent developments, opportunities and challenges in intellectual property rights and access to affordable medicines in China. In particular, the paper finds that there have been impressive achievements in the national response to the HIV epidemic in China. Examples include the rapid expansion of government-supported antiretroviral (ARV) schemes and the development of a legal framework on intellectual property to address access to affordable pharmaceutical products in China. Adoption of the National Intellectual Property Strategy by the State Council in June 2008, and the revisions to the Patent Law and the Implementing Regulations with strong focus on public health protection are among the most prominent legal and policy achievements over the recent years, founding an enabling environment for action.



Download this publication

Compendium of Judgments: Background Material - Judicial Dialogue on HIV, Human Rights and the Law in Asia and the Pacific, Bangkok 2-4 June 2013. Citro B, Avafia T, Fidalgo TM, et al. (2013)

Compendium of_Judgments_2013-1

This compendium focuses on a subset of the many issues that are critical to an effective HIV response. It emphasizes a set of core issues in line with those discussed at the Judicial Dialogue on HIV, Human Rights and the Law in Asia and the Pacific , 2–4 June 2013, Bangkok, Thailand. They are:  

• non-discrimination, including employment discrimination, discrimination in health care settings, and discrimination in other settings

• access to medicines

• same-sex relations

• rights of transgender persons

• rights of sex workers

• rights of people who use drugs



Download publication


Highlighted publications
Calendar of events
(11 Jul - 11 Jul)
(28 Jul - 28 Jul)